Mereo BioPharma has announced that it will merge with OncoMed Pharmaceuticals through the issuance of new Mereo shares (in the form of ADRs). The deal is anticipated to close in H119, with a final ownership split of 75% Mereo/25% OncoMed.
07 Dec 2018
Merger with NASDAQ-listed OncoMed
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Merger with NASDAQ-listed OncoMed
- Published:
07 Dec 2018 -
Author:
Mick Cooper PhD -
Pages:
2
Mereo BioPharma has announced that it will merge with OncoMed Pharmaceuticals through the issuance of new Mereo shares (in the form of ADRs). The deal is anticipated to close in H119, with a final ownership split of 75% Mereo/25% OncoMed.